An faɗaɗa alamar feshin hanci na adrenaline na Neffy (ta Hukumar Abinci da Magunguna ta Amurka) don haɗawa da yara 'yan shekara huɗu zuwa sama waɗanda nauyinsu ya kama daga kilogiram 15 zuwa ƙasa da 30.
Tun da farko a ranar 9 ga Agusta 2025, an amince da Neffy don maganin gaggawa na rashin lafiyar nau'in 1, gami da waɗanda ke barazana ga rayuwa, ga manya da yara waɗanda nauyinsu ya kai akalla kilogiram 30 (fam 66). Shi ne feshin hanci na farko da FDA ta amince da shi don magance anaphylaxis kuma shine samfurin epinephrine na farko don maganin anaphylaxis wanda ba a yi masa allura ba.
A ranar 28 ga Yuni 2024, Hukumar Kula da Magunguna ta Turai (EMA) ta ba Eurneffy, feshin adrenaline na farko na hanci don maganin gaggawa daga halayen rashin lafiyan (anaphylaxis) izinin tallatawa a Tarayyar Turai (EU).
Feshin adrenaline na hanci don maganin gaggawa daga rashin lafiyar jiki (anaphylaxis) yana jiran izini a cikin United Kingdom da Kanada.
Amincewa da feshin hanci na adrenaline don maganin gaggawa game da rashin lafiyan halayen yana ba da madadin hanyar gudanar da adrenaline ga waɗanda (musamman yara) ƙin allura kuma suna fuskantar yanayin barazanar rayuwa na anaphylaxis.
Adrenaline (wanda aka fi sani da epinephrine ) ita ce kawai maganin ceton rai ga anaphylaxis. Ana samunsa ne kawai a matsayin allurar da aka saba bayarwa ta hanyar intramuscular (IM) ko ta hanyar jijiya (IV). Neffy/ Eurneffy shine maganin epinephrine na farko don maganin anaphylaxis wanda ba a yi masa allura ba. Feshi ne na hanci sau ɗaya da aka yi masa a cikin hanci ɗaya. Ana iya ba da allura ta biyu (ta amfani da sabon feshi na hanci a kan hanci ɗaya) idan babu wani ci gaba a alamun ko kuma alamun sun tsananta. Marasa lafiya na iya buƙatar neman taimakon gaggawa na likita don sa ido sosai.
Ana ganin anaphylaxis a matsayin gaggawar likita. Abu ne mai tsanani, rashin lafiyar jiki mai barazanar rai wanda yawanci ya ƙunshi sassan jiki da yawa. Wasu abinci, magunguna da ƙwari sune abubuwan da ke haifar da anaphylaxis. Alamomin cutar yawanci suna faruwa a cikin mintuna kaɗan na fallasa kuma sun haɗa da, amma ba'a iyakance su ba, amya, kumburi, ƙaiƙayi, amai, wahalar numfashi da asarar sani.
***
References:
- Sakin Labaran FDA -FDA Roundup: 7 Maris 2025. Akwai a https://www.fda.gov/news-events/press-announcements/fda-roundup-march-7-2025
- EMA. Labarai - Na farko hanci adrenaline fesa don maganin gaggawa a kan rashin lafiyan halayen. An buga 28 Yuni 2024. Akwai a https://www.ema.europa.eu/en/news/first-nasal-adrenaline-spray-emergency-treatment-against-allergic-reactions
- Fayilolin Magunguna na ARS don Amincewa da Neffy® a Kanada da Burtaniya akan Madadin Abokin Hulɗar Lasisi ALK-Abelló A/S. An buga 6 Janairu 2025. Akwai a https://ir.ars-pharma.com/news-releases/news-release-details/ars-pharmaceuticals-files-approval-neffyr-canada-and-united
***
Labari mai dangantaka
- Epinephrine (ko Adrenaline) Nasal Fesa don Maganin Anaphylaxis (10 Agusta 2024)
- Sabon Magani Mai Sauki Ga Allolin Gyada (15 Nuwamba 2018)
- Dabarar Jiki: Sabuwar Hanyar Rigakafi Don Magance Allergy (15 Afrilu 2018)
***
 to include children four years of age and older who weigh 15 to less than 30 kg.){kind=link}